|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: micronized oral progesteroneFrom: John Robertson (jgmr@unixg.ubc.ca)Tue Dec 31 19:30:38 1996
---------- > From: dahmd@gate.net > To: Multiple recipients of list <ob-gyn-l@talk.obgyn.net> > Subject: micronized oral progesterone > Date: Monday, December 30, 1996 12:19 PM > > Dear colleagues- > > A number of patients are approaching me about using micronized oral > progesterone (MP) instead of using medroxyprogesterone acetate (MPA, usually > marketed as "Provera" in the U.S.). I have seen a few studies, including the > PEPI trial, that support the use of MP over MPA. My take on the literature > is that 100mg each day of the month as part of a continuous hormone > replacement regimen, or 300mg/day for 10 days a month as part of a cyclic
> regimen, will result in atrophic endometria. This is available in Canada as Prometrium. It is used as 200mg/day for 14 days or 300mg/day for 10 days. Appears to be as affective as Provera, and some patients find it has less side effects. I have used a lot of this stuff with good results so far. J.G.M.Robertson MD, 109-9181 Main St. Chilliwack, B.C., Canada, V2P 3M9 (604) 793-9988 e-mail jgmr@unixg.ubc.ca The best we can do for one another is to exchange our thoughts freely; and that, after all, is about all. James A. Froude (1818-1894)
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:20:21 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.